Preoperative aspirin use and its effect on adverse events in patients undergoing cardiac operations

Jiapeng Huang, Macarius Donneyong, Jaimin Trivedi, April Barnard, John Chaney, Adam Dotson, Sherri Raymer, Allen Cheng, Hong Liu, Mark S. Slaughter

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background Preoperative aspirin use within 5 days of cardiac operations is controversial. Aspirin could reduce cardiovascular complications and yet might increase risk of bleeding. Recent reports showed conflicting results, and whether aspirin has variable effects for different cardiac surgical procedures is unclear. Methods A single-center retrospective cohort analysis was performed. After propensity score matching (PSM) for identified confounders, the relationship between preoperative aspirin use and 30-day all-cause mortality, postoperative renal failure, major adverse cardiocerebral events (MACE), blood transfusion, reoperation for bleeding, and postoperative infection were estimated with separate logistic regression models. Results Preoperative aspirin therapy was associated with a 49% (p = 0.04) increased risk of reoperation for bleeding among 868 matched pairs of patients undergoing valve operations. Among 725 matched patients undergoing coronary artery bypass grafting (CABG), preoperative aspirin therapy was not associated with a statistically significant higher risk of reoperation for bleeding. However, preoperative aspirin use, compared with nonuse, was not associated with risks of MACE, 30-day mortality, postoperative renal failure, blood transfusion, or postoperative infection in the entire cohort, in patients undergoing valve operations only, and in patients undergoing CABG only after PSM. Conclusions Preoperative aspirin use in all patients undergoing cardiac operations was not associated with risks of major cardiac, cerebral, or renal complications and infections and death; however, the risk of reoperation for bleeding was elevated among preoperative aspirin users compared with nonusers in a subpopulation of patients undergoing valve operations only.

Original languageEnglish (US)
Pages (from-to)1975-1981
Number of pages7
JournalAnnals of Thoracic Surgery
Volume99
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Aspirin
Reoperation
Hemorrhage
Propensity Score
Coronary Artery Bypass
Blood Transfusion
Renal Insufficiency
Infection
Logistic Models
Cardiac Surgical Procedures
Mortality
Cohort Studies
Kidney
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Huang, J., Donneyong, M., Trivedi, J., Barnard, A., Chaney, J., Dotson, A., ... Slaughter, M. S. (2015). Preoperative aspirin use and its effect on adverse events in patients undergoing cardiac operations. Annals of Thoracic Surgery, 99(6), 1975-1981. https://doi.org/10.1016/j.athoracsur.2015.02.032

Preoperative aspirin use and its effect on adverse events in patients undergoing cardiac operations. / Huang, Jiapeng; Donneyong, Macarius; Trivedi, Jaimin; Barnard, April; Chaney, John; Dotson, Adam; Raymer, Sherri; Cheng, Allen; Liu, Hong; Slaughter, Mark S.

In: Annals of Thoracic Surgery, Vol. 99, No. 6, 01.06.2015, p. 1975-1981.

Research output: Contribution to journalArticle

Huang, J, Donneyong, M, Trivedi, J, Barnard, A, Chaney, J, Dotson, A, Raymer, S, Cheng, A, Liu, H & Slaughter, MS 2015, 'Preoperative aspirin use and its effect on adverse events in patients undergoing cardiac operations', Annals of Thoracic Surgery, vol. 99, no. 6, pp. 1975-1981. https://doi.org/10.1016/j.athoracsur.2015.02.032
Huang, Jiapeng ; Donneyong, Macarius ; Trivedi, Jaimin ; Barnard, April ; Chaney, John ; Dotson, Adam ; Raymer, Sherri ; Cheng, Allen ; Liu, Hong ; Slaughter, Mark S. / Preoperative aspirin use and its effect on adverse events in patients undergoing cardiac operations. In: Annals of Thoracic Surgery. 2015 ; Vol. 99, No. 6. pp. 1975-1981.
@article{a4a60a2e9db14c259828ec703df237dd,
title = "Preoperative aspirin use and its effect on adverse events in patients undergoing cardiac operations",
abstract = "Background Preoperative aspirin use within 5 days of cardiac operations is controversial. Aspirin could reduce cardiovascular complications and yet might increase risk of bleeding. Recent reports showed conflicting results, and whether aspirin has variable effects for different cardiac surgical procedures is unclear. Methods A single-center retrospective cohort analysis was performed. After propensity score matching (PSM) for identified confounders, the relationship between preoperative aspirin use and 30-day all-cause mortality, postoperative renal failure, major adverse cardiocerebral events (MACE), blood transfusion, reoperation for bleeding, and postoperative infection were estimated with separate logistic regression models. Results Preoperative aspirin therapy was associated with a 49{\%} (p = 0.04) increased risk of reoperation for bleeding among 868 matched pairs of patients undergoing valve operations. Among 725 matched patients undergoing coronary artery bypass grafting (CABG), preoperative aspirin therapy was not associated with a statistically significant higher risk of reoperation for bleeding. However, preoperative aspirin use, compared with nonuse, was not associated with risks of MACE, 30-day mortality, postoperative renal failure, blood transfusion, or postoperative infection in the entire cohort, in patients undergoing valve operations only, and in patients undergoing CABG only after PSM. Conclusions Preoperative aspirin use in all patients undergoing cardiac operations was not associated with risks of major cardiac, cerebral, or renal complications and infections and death; however, the risk of reoperation for bleeding was elevated among preoperative aspirin users compared with nonusers in a subpopulation of patients undergoing valve operations only.",
author = "Jiapeng Huang and Macarius Donneyong and Jaimin Trivedi and April Barnard and John Chaney and Adam Dotson and Sherri Raymer and Allen Cheng and Hong Liu and Slaughter, {Mark S.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.athoracsur.2015.02.032",
language = "English (US)",
volume = "99",
pages = "1975--1981",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Preoperative aspirin use and its effect on adverse events in patients undergoing cardiac operations

AU - Huang, Jiapeng

AU - Donneyong, Macarius

AU - Trivedi, Jaimin

AU - Barnard, April

AU - Chaney, John

AU - Dotson, Adam

AU - Raymer, Sherri

AU - Cheng, Allen

AU - Liu, Hong

AU - Slaughter, Mark S.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Background Preoperative aspirin use within 5 days of cardiac operations is controversial. Aspirin could reduce cardiovascular complications and yet might increase risk of bleeding. Recent reports showed conflicting results, and whether aspirin has variable effects for different cardiac surgical procedures is unclear. Methods A single-center retrospective cohort analysis was performed. After propensity score matching (PSM) for identified confounders, the relationship between preoperative aspirin use and 30-day all-cause mortality, postoperative renal failure, major adverse cardiocerebral events (MACE), blood transfusion, reoperation for bleeding, and postoperative infection were estimated with separate logistic regression models. Results Preoperative aspirin therapy was associated with a 49% (p = 0.04) increased risk of reoperation for bleeding among 868 matched pairs of patients undergoing valve operations. Among 725 matched patients undergoing coronary artery bypass grafting (CABG), preoperative aspirin therapy was not associated with a statistically significant higher risk of reoperation for bleeding. However, preoperative aspirin use, compared with nonuse, was not associated with risks of MACE, 30-day mortality, postoperative renal failure, blood transfusion, or postoperative infection in the entire cohort, in patients undergoing valve operations only, and in patients undergoing CABG only after PSM. Conclusions Preoperative aspirin use in all patients undergoing cardiac operations was not associated with risks of major cardiac, cerebral, or renal complications and infections and death; however, the risk of reoperation for bleeding was elevated among preoperative aspirin users compared with nonusers in a subpopulation of patients undergoing valve operations only.

AB - Background Preoperative aspirin use within 5 days of cardiac operations is controversial. Aspirin could reduce cardiovascular complications and yet might increase risk of bleeding. Recent reports showed conflicting results, and whether aspirin has variable effects for different cardiac surgical procedures is unclear. Methods A single-center retrospective cohort analysis was performed. After propensity score matching (PSM) for identified confounders, the relationship between preoperative aspirin use and 30-day all-cause mortality, postoperative renal failure, major adverse cardiocerebral events (MACE), blood transfusion, reoperation for bleeding, and postoperative infection were estimated with separate logistic regression models. Results Preoperative aspirin therapy was associated with a 49% (p = 0.04) increased risk of reoperation for bleeding among 868 matched pairs of patients undergoing valve operations. Among 725 matched patients undergoing coronary artery bypass grafting (CABG), preoperative aspirin therapy was not associated with a statistically significant higher risk of reoperation for bleeding. However, preoperative aspirin use, compared with nonuse, was not associated with risks of MACE, 30-day mortality, postoperative renal failure, blood transfusion, or postoperative infection in the entire cohort, in patients undergoing valve operations only, and in patients undergoing CABG only after PSM. Conclusions Preoperative aspirin use in all patients undergoing cardiac operations was not associated with risks of major cardiac, cerebral, or renal complications and infections and death; however, the risk of reoperation for bleeding was elevated among preoperative aspirin users compared with nonusers in a subpopulation of patients undergoing valve operations only.

UR - http://www.scopus.com/inward/record.url?scp=84930923830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930923830&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2015.02.032

DO - 10.1016/j.athoracsur.2015.02.032

M3 - Article

C2 - 25912742

AN - SCOPUS:84930923830

VL - 99

SP - 1975

EP - 1981

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 6

ER -